The influence of simultaneous lateral grafting on clinical outcomes following one‐stage implant placement A cross‐sectional analysis

Abstract Background To evaluate the prevalence of peri-implant disease after immediate implant placement and loading. Material and methods This cross-sectional analysis included a total of 47 patients with 64 implants exhibiting a mean loading time of 2 to 10 years (4.23 ± 1.7 years). The surgical and prosthetic procedures were standardized in all patients. Peri-implant health and disease was assessed based on the established case definitions. Results The prevalence of peri-implant health, peri-implant mucositis, and peri-implantitis amounted to 38.3%, 57.5%, and 4.2% of the patients, respectively. Mucosal recession of 1 mm was present at 4 (6%) implants. No suppuration, pain, or implant failures were reported. Ordinal logistic regression revealed that reduced keratinized mucosa height was significantly associated with the diagnosis of peri-implant mucositis and peri-implantitis (OR = 0.514, P = 0.0125). Conclusion Immediate implant placement and loading was associated with high success rates at 2 to 10 years.

Download Full-text

Clinical Outcomes and Costs Associated with In-hospital Biliary Complications After Liver Transplantation: a Cross-Sectional Analysis

Journal of Gastrointestinal Surgery ◽

10.1007/s11605-014-2675-1 ◽

2014 ◽

Vol 19 (2) ◽

pp. 282-289 ◽

Cited By ~ 2

Author(s):

Arun P. Palanisamy ◽

D. J. Taber ◽

A. G. Sutter ◽

S. N. Nadig ◽

J. E. Dowden ◽

...

Keyword(s):

Liver Transplantation ◽

Clinical Outcomes ◽

Biliary Complications ◽

Cross Sectional ◽

Cross Sectional Analysis ◽

Sectional Analysis

Download Full-text

The prevalence of peri‐implant disease following immediate implant placement and loading A cross‐sectional analysis after 2 to 10‐years

Clinical Oral Implants Research ◽

10.1111/clr.131_13644 ◽

2020 ◽

Vol 31 (S20) ◽

pp. 189-189

Author(s):

Puria Parvini ◽

Karina Obreja ◽

Kathrin Becker ◽

Amira Begic ◽

Frank Schwarz ◽

...

Keyword(s):

Cross Sectional ◽

Cross Sectional Analysis ◽

Implant Placement ◽

Immediate Implant ◽

Sectional Analysis

Download Full-text

Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration’s recommendation: a cross-sectional analysis in New York

BMJ Open ◽

10.1136/bmjopen-2020-042965 ◽

2021 ◽

Vol 11 (2) ◽

pp. e042965

Author(s):

Eun Ji Kim ◽

Kevin Coppa ◽

Jamie S Hirsch ◽

Sara Abrahams ◽

Jennifer Johnson ◽

...

Keyword(s):

Clinical Outcomes ◽

Disease Severity ◽

Composite Outcome ◽

Cross Sectional ◽

Cross Sectional Analysis ◽

Fda Approval ◽

Hospitalised Patients ◽

Number Of Patients ◽

The Us ◽

Sectional Analysis

ObjectiveTo describe the pattern of hydroxychloroquine use and examine the association between hydroxychloroquine use and clinical outcomes arising from changes in the US Food and Drug Administration (FDA)’s recommendation during the coronavirus disease 2019 (COVID-19) pandemic.DesignA retrospective cross-sectional analysis.Setting and participantsWe included hospitalised adult patients at Northwell Health hospitals with confirmed COVID-19 infections between 1 March 2020 and 11 May 2020. We categorised changes in the FDA’s recommendation as pre-FDA approval (1 March 2020–27 March 2020), FDA approval (28 March 2020–23 April 2020), and FDA warning (24 April 2020–11 May 2020). The hydroxychloroquine-treated group received at least one dose within 48 hours of hospital admission.Primary outcomeA composite of intubation and inpatient death.ResultsThe percentages of patients who were treated with hydroxychloroquine were 192/2202 (8.7%) pre-FDA approval, 2902/6741 (43.0%) FDA approval, and 176/1066 (16.5%) FDA warning period (p<0.001). Using propensity score matching, there was a higher rate of the composite outcome among patients treated with hydroxychloroquine (49/192, 25.5%) compared with no hydroxychloroquine (66/384, 17.2%) in the pre-FDA approval period (p=0.03) but not in the FDA approval period (25.5% vs 22.6%, p=0.08) or the FDA warning (21.0% vs 15.1%, p=0.11) periods. Coincidently, there was an increase in number of patients with COVID-19 and disease severity during the FDA approval period (24.1% during FDA approval vs 21.4% during pre-FDA approval period had the composite outcome). Hydroxychloroquine use was associated with increased odds of the composite outcome during the pre-FDA approval period (OR=1.65 (95% CI 1.09 to 2.51)) but not during the FDA approval (OR=1.17 (95% CI 0.99 to 1.39)) and FDA warning (OR=1.50 (95% CI 0.94 to 2.39)) periods.ConclusionsHydroxychloroquine use was associated with adverse clinical outcomes only during the pre-FDA approval period but not during the FDA approval and warning periods, even after adjusting for concurrent changes in the percentage of patients with COVID-19 treated with hydroxychloroquine and the number (and disease severity) of hospitalised patients with COVID-19 infections.

Download Full-text

A Cross-Sectional Analysis of Clinical Outcomes Following Chiropractic Care in Veterans With and Without Post-Traumatic Stress Disorder

Military Medicine ◽

10.7205/milmed-d-02-3508 ◽

2009 ◽

Vol 174 (6) ◽

pp. 578-583 ◽

Cited By ~ 25

Author(s):

Andrew S. Dunn ◽

Steven R. Passmore ◽

Jeanmarie Burke ◽

David Chicoine

Keyword(s):

Clinical Outcomes ◽

Post Traumatic Stress Disorder ◽

Traumatic Stress ◽

Stress Disorder ◽

Chiropractic Care ◽

Post Traumatic Stress ◽

Cross Sectional ◽

Cross Sectional Analysis ◽

Post Traumatic ◽

Sectional Analysis

Download Full-text

Medication adherence and clinical outcomes in dispensing and non-dispensing practices: a cross-sectional analysis

British Journal of General Practice ◽

10.3399/bjgp20x713861 ◽

2020 ◽

Vol 71 (702) ◽

pp. e55-e61

Author(s):

Mayam Gomez-Cano ◽

Bianca Wiering ◽

Gary Abel ◽

John L Campbell ◽

Christopher E Clark

Keyword(s):

Medication Adherence ◽

Clinical Outcomes ◽

Prescribing Practices ◽

Cross Sectional ◽

Blood Pressure Targets ◽

Cross Sectional Analysis ◽

Dispensing Practices ◽

General Practices ◽

Underlying Mechanisms ◽

Sectional Analysis

BackgroundMost patients obtain medications from pharmacies by prescription, but rural general practices can dispense medications. The clinical implications of this difference in drug delivery are unknown. This study hypothesised that dispensing status may be associated with better medication adherence. This could impact intermediate clinical outcomes dependent on medication adherence in, for example, hypertension or diabetes.AimTo investigate whether dispensing status is associated with differences in achievement of Quality and Outcomes Framework (QOF) indicators that rely on medication adherence.Design and settingCross-sectional analysis of QOF data for 7392 general practices in England.MethodQOF data from 1 April 2016 to 31 March 2017 linked to dispensing status for general practices with list sizes ≥1000 in England were analysed. QOF indicators were categorised according to whether their achievement depended on a record of prescribing only, medication adherence, or neither. Differences were estimated between dispensing and non-dispensing practices using mixed-effects logistic regression, adjusting for practice population age, sex, deprivation, list size, single-handed status, and rurality.ResultsData existed for 7392 practices; 1014 (13.7%) could dispense. Achievement was better in dispensing practices than in non-dispensing practices for seven of nine QOF indicators dependent on adherence, including blood pressure targets. Only one of ten indicators dependent on prescribing but not adherence displayed better achievement; indicators unrelated to prescribing showed a trend towards higher achievement by dispensing practices.ConclusionDispensing practices may achieve better clinical outcomes than prescribing practices. Further work is required to explore underlying mechanisms for these observations and to directly study medication adherence rates.

Download Full-text